SCHEMBL19828095

SCHEMBL19828095

COc1ccc2c(c1)CO[C@@H](C)C2N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.42
DRD2 P14416 1/20 0.42
DRD3 P35462 1/20 0.42
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
HTR2A P28223 2/20 0.40
CHRNA7 P36544 2/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
KDM1A O60341 1/20 0.38
DRD1 P21728 1/20 0.38
HTR2B P41595 1/20 0.37
ABCB1 P08183 1/20 0.36
OPRM1 P35372 1/20 0.36
CYP19A1 P11511 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19828077 1.00 HTR2C (0.42) HTR2CDRD2DRD3ESR1ESR2
SCHEMBL19835778 1.00 HTR2C (0.42) HTR2CDRD2DRD3ESR1ESR2
SCHEMBL19830056 1.00 HTR2C (0.42) HTR2CDRD2DRD3ESR1ESR2
SCHEMBL19830057 1.00 HTR2C (0.42) HTR2CDRD2DRD3ESR1ESR2
SCHEMBL19829979 0.88 HTR2A (0.43) HTR2CDRD2DRD3HTR2AKDM1A
SCHEMBL19829977 0.88 HTR2A (0.43) HTR2CDRD2DRD3HTR2AKDM1A
SCHEMBL19828169 0.88 HTR2A (0.43) HTR2CDRD2DRD3HTR2AKDM1A
SCHEMBL19828033 0.88 HTR2A (0.43) HTR2CDRD2DRD3HTR2AKDM1A
SCHEMBL19829978 0.88 HTR2A (0.43) HTR2CDRD2DRD3HTR2AKDM1A
SCHEMBL19835922 0.88 HTR2A (0.43) HTR2CDRD2DRD3HTR2AKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018023070-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF SUNOVION PHARMACEUTICALS, INC. (US) 2018-02-01 WO disclosed
US-20180028492-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF PGI DRUG DISCOVERY LLC 2018-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180028492-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF ACHE, CHAT, MAOB HTR2C 196/4885DRD2 447/4885DRD3 629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.